Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yokohama
Clinical trial register · Japan

Clinical Trials in Yokohama, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Nagoya 31 Yokohama 27 Kashiwa 20 Sapporo 20 Sendai 18
Narrow the registerReset
Recruitment status
Phase
Site location
Nagoya31 Yokohama27 Kashiwa20 Sapporo20 Sendai18
All 142 locations
Target enrolment
to

Trials with a site in Yokohama

27 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
Pfizer
Phase 3
197
Fukuoka, Kasuya-gun, Sapporo, Amagasaki, Mito, Naka, Yokohama, Minoh
2026-09-28
Recruiting
Pfizer
Phase 3
1,375
Nagoya, Kagoshima, Yokohama, Sakai, Saitama, Chuo-ku, Tachikawa, Toshima-ku
2026-08-24
Recruiting
Pfizer
Phase 1/2
224
Yokohama, Suita, Shinjuku-ku, Fukuoka, Yamagata
2026-02-10
Recruiting
Pfizer
Phase 3
800
Nagoya, Chiba, Kashiwa, Yokohama, Hidaka, Kitaadachi-gun, Nagaizumi-cho, Koto-ku
2025-12-11
Recruiting
Pfizer
Phase 3
450
Yokohama, Sakai, Setagaya-ku, Fukuoka
2025-12-02
Recruiting
Pfizer
Phase 2
165
Takasaki, Kawasaki-shi, Yokohama, Sakai, Chuo-ku
2025-11-20
Recruiting
Pfizer
Phase 2
200
Takasaki, Yokohama, Sakai, Tachikawa, Miyazaki
2025-10-30
Recruiting
Pfizer
Phase 2/3
982
Nagoya, Chiba, Kashiwa, Kita-gun, Kawasaki, Yokohama, Suita, Nagaizumi-cho
2025-10-03
Recruiting
Pfizer
Phase 3
1,000
Chiba, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka, Suita
2025-09-28
Recruiting
Pfizer
Phase 3
150
Yokohama, Sakai, Setagaya-ku, Fukuoka
2025-07-24
Recruiting
Pfizer
Phase 3
714
Tōon, Kurume, Otashi, Asahikawa, Kobe, Yokohama, Tsu, Sendai
2025-07-23
Active, closed
Pfizer
Phase 1/2
74
Nagoya, Yokohama, Suita, Chuo-ku, Koto
2025-06-30
Recruiting
Pfizer
Phase 2
620
Kasugai, Matsudo, Sakura, Sapporo, Koga, Sagamihara, Yokohama, Tsu
2025-06-19
Active, closed
Pfizer
Phase 3
1,035
Nagoya, Otashi, Sapporo, Yokohama, Sakyo-ku, Sendai, Suita, Bunkyo-ku
2025-01-06
Recruiting
Pfizer
Phase 3
900
Chiba, Kashiwa, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka
2024-10-22
Active, closed
Pfizer
Phase 3
600
Chiba, Kashiwa, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka
2024-10-21
Active, closed
Pfizer
Phase 1/2
71
Kashiwa, Yokohama, Chuo-ku, Tokyo
2024-02-19
Recruiting
Pfizer
Phase 2
340
Yokohama, Osaka, Chuo-ku, Setagaya-ku
2023-08-22
Active, closed
Pfizer
Phase 3
624
Nagoya, Chiba, Kashiwa, Sapporo, Yokohama, Suita, Ina-machi, Bunkyo-ku
2023-03-03
Active, closed
Pfizer
Phase 3
38,861
Fukuoka, Itoshima, Amagasaki, Yokohama, Osaka, Kawaguchi, Chuo-ku, Hachioji-shi
2021-08-31
Active, closed
Pfizer
Phase 3
841
Chiba, Kashiwa, Sapporo, Kanazawa, Kawasaki, Yokohama, Nagoya, Osaka
2020-12-21
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Nagoya, Kashiwa, Yokohama, Chuo-ku
2020-11-16
Active, closed
Pfizer
Phase 3
1,068
Matsuyama, Tōon, Fukuoka, Ōta, Sapporo, Yokohama, Osaka, Sakai
2019-12-30
Active, closed
Pfizer
Phase 3
1,054
Nagoya, Hirosaki, Kashiwa, Matsuyama, Kure, Sapporo, Kanazawa, Yokohama
2017-12-18
Active, closed
Pfizer
Phase 3
296
Nagoya, Matsuyama, Kurume, Sapporo, Kanazawa, Yokohama, Sendai, Osaka
2017-04-27
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/yokohama

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Yokohama that also match the filters currently applied.

How many clinical trials are recruiting in Yokohama?

15 of the 27 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yokohama), 27 studies
PhaseStudiesRecruitingShare
Phase 317863%
Phase 26522.2%
Phase 1/23111.1%
Phase 2/3113.7%

Most active sponsors

Lead sponsors with the most studies (Yokohama)
Lead sponsorStudiesRecruiting
Pfizer2715
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.